Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice. / Dall, Morten; Penke, Melanie; Sulek, Karolina; Matz-Soja, Madlen; Holst, Birgitte; Garten, Antje; Kiess, Wieland; Treebak, Jonas T.

In: Molecular and Cellular Endocrinology, Vol. 473, 2018, p. 245-256.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Dall, M, Penke, M, Sulek, K, Matz-Soja, M, Holst, B, Garten, A, Kiess, W & Treebak, JT 2018, 'Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice', Molecular and Cellular Endocrinology, vol. 473, pp. 245-256. https://doi.org/10.1016/j.mce.2018.01.025

APA

Dall, M., Penke, M., Sulek, K., Matz-Soja, M., Holst, B., Garten, A., Kiess, W., & Treebak, J. T. (2018). Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice. Molecular and Cellular Endocrinology, 473, 245-256. https://doi.org/10.1016/j.mce.2018.01.025

Vancouver

Dall M, Penke M, Sulek K, Matz-Soja M, Holst B, Garten A et al. Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice. Molecular and Cellular Endocrinology. 2018;473:245-256. https://doi.org/10.1016/j.mce.2018.01.025

Author

Dall, Morten ; Penke, Melanie ; Sulek, Karolina ; Matz-Soja, Madlen ; Holst, Birgitte ; Garten, Antje ; Kiess, Wieland ; Treebak, Jonas T. / Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice. In: Molecular and Cellular Endocrinology. 2018 ; Vol. 473. pp. 245-256.

Bibtex

@article{7ca403bff0a44dfcadf355da077721ab,
title = "Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice",
abstract = "Dietary supplementation of nicotinamide adenine dinucleotide (NAD+) precursors has been suggested as a treatment for non-alcoholic fatty liver disease and obesity. In the liver, NAD+is primarily generated by nicotinamide phosphoribosyltransferase (NAMPT), and hepatic levels of NAMPT and NAD+have been reported to be dependent on age and body composition. The aim of the present study was to identify time course-dependent changes in hepatic NAD content and NAD+salvage capacity in mice challenged with a high-fat diet (HFD). We fed 7-week-old C57BL/6JBomTac male mice either regular chow or a 60% HFD for 6, 12, 24, and 48 weeks, and we evaluated time course-dependent changes in whole body metabolism, liver steatosis, and abundance of hepatic NAD-associated metabolites and enzymes. Mice fed a 60% HFD rapidly accumulated fat and hepatic triglycerides with associated changes in respiratory exchange ratio (RER) and a disruption of the circadian feeding pattern. The HFD did not alter hepatic NAD+levels, but caused a decrease in NADP+and NADPH levels. Decreased NADP+content was not accompanied by alterations in NAD kinase (NADK) abundance in HFD-fed mice, but NADK levels increased with age regardless of diet. NAMPT protein abundance did not change with age or diet. HFD consumption caused a severe decrease in protein lysine malonylation after six weeks, which persisted throughout the experiment. This decrease was not associated with changes in SIRT5 abundance. In conclusion, hepatic NAD+salvage capacity is resistant to long-term HFD feeding, and hepatic lipid accumulation does not compromise the hepatic NAD+pool in HFD-challenged C57BL/6JBomTac male mice.",
keywords = "Journal Article",
author = "Morten Dall and Melanie Penke and Karolina Sulek and Madlen Matz-Soja and Birgitte Holst and Antje Garten and Wieland Kiess and Treebak, {Jonas T.}",
note = "Copyright {\textcopyright} 2018 Elsevier B.V. All rights reserved.",
year = "2018",
doi = "10.1016/j.mce.2018.01.025",
language = "English",
volume = "473",
pages = "245--256",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",

}

RIS

TY - JOUR

T1 - Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice

AU - Dall, Morten

AU - Penke, Melanie

AU - Sulek, Karolina

AU - Matz-Soja, Madlen

AU - Holst, Birgitte

AU - Garten, Antje

AU - Kiess, Wieland

AU - Treebak, Jonas T.

N1 - Copyright © 2018 Elsevier B.V. All rights reserved.

PY - 2018

Y1 - 2018

N2 - Dietary supplementation of nicotinamide adenine dinucleotide (NAD+) precursors has been suggested as a treatment for non-alcoholic fatty liver disease and obesity. In the liver, NAD+is primarily generated by nicotinamide phosphoribosyltransferase (NAMPT), and hepatic levels of NAMPT and NAD+have been reported to be dependent on age and body composition. The aim of the present study was to identify time course-dependent changes in hepatic NAD content and NAD+salvage capacity in mice challenged with a high-fat diet (HFD). We fed 7-week-old C57BL/6JBomTac male mice either regular chow or a 60% HFD for 6, 12, 24, and 48 weeks, and we evaluated time course-dependent changes in whole body metabolism, liver steatosis, and abundance of hepatic NAD-associated metabolites and enzymes. Mice fed a 60% HFD rapidly accumulated fat and hepatic triglycerides with associated changes in respiratory exchange ratio (RER) and a disruption of the circadian feeding pattern. The HFD did not alter hepatic NAD+levels, but caused a decrease in NADP+and NADPH levels. Decreased NADP+content was not accompanied by alterations in NAD kinase (NADK) abundance in HFD-fed mice, but NADK levels increased with age regardless of diet. NAMPT protein abundance did not change with age or diet. HFD consumption caused a severe decrease in protein lysine malonylation after six weeks, which persisted throughout the experiment. This decrease was not associated with changes in SIRT5 abundance. In conclusion, hepatic NAD+salvage capacity is resistant to long-term HFD feeding, and hepatic lipid accumulation does not compromise the hepatic NAD+pool in HFD-challenged C57BL/6JBomTac male mice.

AB - Dietary supplementation of nicotinamide adenine dinucleotide (NAD+) precursors has been suggested as a treatment for non-alcoholic fatty liver disease and obesity. In the liver, NAD+is primarily generated by nicotinamide phosphoribosyltransferase (NAMPT), and hepatic levels of NAMPT and NAD+have been reported to be dependent on age and body composition. The aim of the present study was to identify time course-dependent changes in hepatic NAD content and NAD+salvage capacity in mice challenged with a high-fat diet (HFD). We fed 7-week-old C57BL/6JBomTac male mice either regular chow or a 60% HFD for 6, 12, 24, and 48 weeks, and we evaluated time course-dependent changes in whole body metabolism, liver steatosis, and abundance of hepatic NAD-associated metabolites and enzymes. Mice fed a 60% HFD rapidly accumulated fat and hepatic triglycerides with associated changes in respiratory exchange ratio (RER) and a disruption of the circadian feeding pattern. The HFD did not alter hepatic NAD+levels, but caused a decrease in NADP+and NADPH levels. Decreased NADP+content was not accompanied by alterations in NAD kinase (NADK) abundance in HFD-fed mice, but NADK levels increased with age regardless of diet. NAMPT protein abundance did not change with age or diet. HFD consumption caused a severe decrease in protein lysine malonylation after six weeks, which persisted throughout the experiment. This decrease was not associated with changes in SIRT5 abundance. In conclusion, hepatic NAD+salvage capacity is resistant to long-term HFD feeding, and hepatic lipid accumulation does not compromise the hepatic NAD+pool in HFD-challenged C57BL/6JBomTac male mice.

KW - Journal Article

U2 - 10.1016/j.mce.2018.01.025

DO - 10.1016/j.mce.2018.01.025

M3 - Journal article

C2 - 29408602

VL - 473

SP - 245

EP - 256

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

ER -

ID: 189765336